{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:06:35Z","timestamp":1788260795650,"version":"build-2803163510"},"reference-count":34,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2020,12,31]]},"DOI":"10.5582\/bst.2020.03326","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T22:41:24Z","timestamp":1606257684000},"page":"428-435","source":"Crossref","is-referenced-by-count":36,"title":["The C-reactive protein to albumin ratio is an excellent prognostic predictor for gallbladder cancer"],"prefix":"10.5582","volume":"14","author":[{"given":"Yongjin","family":"Bao","sequence":"first","affiliation":[{"name":"Department of Hepatopancreatobiliary Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsheng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hepatopancreatobiliary Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Hepatopancreatobiliary Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hepatopancreatobiliary Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibo","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hepatopancreatobiliary Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglin","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Hepatopancreatobiliary Surgery, The Third Affiliated Hospital of Soochow University, Changzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Zhu AX, Hong TS, Hezel AF, Kooby DA. Current management of gallbladder carcinoma. Oncologist. 2010; 15:168-181.","DOI":"10.1634\/theoncologist.2009-0302"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Garg PK, Pandey D, Sharma J. The surgical management of gallbladder cancer. Expert Rev Gastroenterol Hepatol. 2015; 9:155-166.","DOI":"10.1586\/17474124.2014.943188"},{"key":"3","unstructured":"3. Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014; 6:99-109."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68:394-424.","DOI":"10.3322\/caac.21492"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hakeem AR, Papoulas M, Menon KV. The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer - A systematic review. Eur J Surg Oncol. 2019; 45:83-91.","DOI":"10.1016\/j.ejso.2018.08.020"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cziupka K, Partecke LI, Mirow L, Heidecke CD, Emde C, Hoffmann W, Siewert U, van den Berg N, von Bernstorff W, Stier A. Outcomes and prognostic factors in gallbladder cancer: a single-centre experience. Langenbecks Arch Surg. 2012; 397:899-907.","DOI":"10.1007\/s00423-012-0950-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lee W, Jeong CY, Kim YH, <i>et al.<\/i> Validation of the prognostic performance in various nodal staging systems for gallbladder cancer: results of a multicenter study. Langenbecks Arch Surg. 2019; 404:581-588.","DOI":"10.1007\/s00423-019-01807-9"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bai Y, Liu ZS, Xiong JP, Xu WY, Lin JZ, Long JY, Miao F, Huang HC, Wan XS, Zhao HT. Nomogram to predict overall survival after gallbladder cancer resection in China. World J Gastroenterol. 2018; 24:5167-5178.","DOI":"10.3748\/wjg.v24.i45.5167"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Pilgrim CH, Groeschl RT, Turaga KK, Gamblin TC. Key factors influencing prognosis in relation to gallbladder cancer. Dig Dis Sci. 2013; 58:2455-2462.","DOI":"10.1007\/s10620-013-2713-y"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Du Clos TW. Function of C-reactive protein. Ann Med. 2000; 32:274-278.","DOI":"10.3109\/07853890009011772"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Wu XS, Shi LB, Li ML, Ding Q, Weng H, Wu WG, Cao Y, Bao RF, Shu YJ, Ding QC, Mu JS, Gu J, Dong P, Liu YB. Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma. Ann Surg Oncol. 2014; 21:449-457.","DOI":"10.1245\/s10434-013-3292-z"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Zhang L, Wang R, Chen W, Xu X, Dong S, Fan H, Liu C. Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma. HPB (Oxford). 2016; 18:600-607.","DOI":"10.1016\/j.hpb.2016.03.608"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Li P, Huang W, Wang F, Ke YF, Gao L, Shi KQ, Zhou MT, Chen BC. Nomograms based on inflammatory biomarkers for predicting tumor grade and micro-vascular invasion in stage I\/II hepatocellular carcinoma. Biosci Rep. 2018; 38:BSR20180464.","DOI":"10.1042\/BSR20180464"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kano H, Midorikawa Y, Song P, Nakayama H, Moriguchi M, Higaki T, Tsuji S, Takayama T. High C-reactive protein\/albumin ratio associated with reduced survival due to advanced stage of intrahepatic cholangiocarcinoma. Biosci Trends. 2020; 14:304-309.","DOI":"10.5582\/bst.2020.03167"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Abe T, Amano H, Hanada K, Yonehara S, Kobayashi T, Fukuda T, Nakahara M, Kuroda Y, Noriyuki T. Preoperative Systemic Inflammation and Complications Affect Long-term Gallbladder Carcinoma Outcomes Following Surgery with Curative Intent. Anticancer Res. 2016; 36:4887-4894.","DOI":"10.21873\/anticanres.11053"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Osugi J, Muto S, Matsumura Y, Higuchi M, Suzuki H, Gotoh M. Prognostic impact of the high-sensitivity modified Glasgow prognostic score in patients with resectable non-small cell lung cancer. J Cancer Res Ther. 2016; 12:945-951.","DOI":"10.4103\/0973-1482.176168"},{"key":"17","unstructured":"17. Jacobs EL, Haskell CM. Clinical Use of Tumor-Markers in Oncology. Curr Prob Cancer. 1991; 15:299-350."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Proctor MJ, Horgan PG, Talwar D, Fletcher CD, Morrison DS, McMillan DC. Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study. Cancer. 2013; 119:2325-2332.","DOI":"10.1002\/cncr.28018"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988; 44:837-845.","DOI":"10.2307\/2531595"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more &quot;personalized&quot; approach to cancer staging. CA Cancer J Clin. 2017; 67:93-99.","DOI":"10.3322\/caac.21388"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Wang J, Bo X, Shi X, <i>et al.<\/i> Modified staging classification of gallbladder carcinoma on the basis of the 8(th) edition of the American Joint Commission on Cancer (AJCC) staging system. Eur J Surg Oncol. 2020; 46:527-533.","DOI":"10.1016\/j.ejso.2019.10.015"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010; 140:883-899.","DOI":"10.1016\/j.cell.2010.01.025"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008; 454:436-444.","DOI":"10.1038\/nature07205"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Rasmussen LJH, Schultz M, Gaardsting A, Ladelund S, Garred P, Iversen K, Eugen-Olsen J, Helms M, David KP, Kjaer A, Lebech AM, Kronborg G. Inflammatory biomarkers and cancer: CRP and suPAR as markers of incident cancer in patients with serious nonspecific symptoms and signs of cancer. Int J Cancer. 2017; 141:191-199.","DOI":"10.1002\/ijc.30732"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Szkandera J, Stotz M, Absenger G, Stojakovic T, Samonigg H, Kornprat P, Schaberl-Moser R, Alzoughbi W, Lackner C, Ress AL, Seggewies FS, Gerger A, Hoefler G, Pichler M. Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients. Br J Cancer. 2014; 110:183-188.","DOI":"10.1038\/bjc.2013.701"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Nguyen GC, Du L, Chong RY, Jackson TD. Hypoalbuminaemia and Postoperative Outcomes in Inflammatory Bowel Disease: the NSQIP Surgical Cohort. J Crohns Colitis. 2019; 13:1433-1438.","DOI":"10.1093\/ecco-jcc\/jjz083"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ramsey S, Lamb GW, Aitchison M, Graham J, McMillan DC. Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer. Cancer. 2007; 109:205-212.","DOI":"10.1002\/cncr.22400"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer. 2004; 90:1704-1706.","DOI":"10.1038\/sj.bjc.6601789"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Inoue Y, Iwata T, Okugawa Y, Kawamoto A, Hiro J, Toiyama Y, Tanaka K, Uchida K, Mohri Y, Miki C, Kusunoki M. Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer. Oncology. 2013; 84:100-107.","DOI":"10.1159\/000343822"},{"key":"30","unstructured":"30. Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O&apos;Reilly DS, Foulis AK, Horgan PG, McMillan DC. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer. 2011; 47:2633-2641."},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Takeno S, Hashimoto T, Shibata R, Maki K, Shiwaku H, Yamana I, Yamashita R, Yamashita Y. The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor in patients with resectable gastric cancer. Oncology. 2014; 87:205-214.","DOI":"10.1159\/000362601"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Nakamura T, Matsumine A, Asanuma K, Matsubara T, Sudo A. The value of the high-sensitivity modified Glasgow prognostic score in predicting the survival of patients with a soft-tissue sarcoma. Bone Joint J. 2015; 97-B:847-852.","DOI":"10.1302\/0301-620X.97B.35098"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Tanaka K, Fushiya N, Koike K, Nishino H, Matsushima M. The C-reactive protein\/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol. 2015; 22:803-810.","DOI":"10.1245\/s10434-014-4048-0"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Liu F, Hu HJ, Ma WJ, Yang Q, Wang JK, Li FY. Prognostic significance of neutrophil-lymphocyte ratio and carbohydrate antigen 19-9 in patients with gallbladder carcinoma. Medicine. 2019; 98:e14550.","DOI":"10.1097\/MD.0000000000014550"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/14\/6\/14_2020.03326\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T03:46:59Z","timestamp":1611373619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/14\/6\/14_2020.03326\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,31]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.2020.03326","relation":{},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"value":"1881-7815","type":"print"},{"value":"1881-7823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,31]]}}}